(Q34753908)

English

Production and characterization of highly tumor-specific rat monoclonal antibodies recognizing the extracellular domain of human L-type amino-acid transporter 1.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Production and characterization of highly tumor-specific rat monoclonal antibodies recognizing the extracellular domain of human L-type amino-acid transporter 1. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

object named as

Hideki Yagi

4

0 references

author name string

Yoshiya Ohno

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Kentaro Suda

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Kazue Masuko

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Yoshiyuki Hashimoto

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Takashi Masuko

6

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

24 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1000-1007

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

The 4F2hc surface antigen is necessary for expression of system L-like neutral amino acid-transport activity in C6-BU-1 rat glioma cells: evidence from expression studies in Xenopus laevis oocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Malignant transformation of NIH3T3 cells by overexpression of early lymphocyte activation antigen CD98.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Enhanced tumorigenicity caused by truncation of the extracellular domain of GP125/CD98 heavy chain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Transformation of BALB3T3 cells caused by over-expression of rat CD98 heavy chain (HC) requires its association with light chain: mis-sense mutation in a cysteine residue of CD98HC eliminates its transforming activity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Complementation of dominant suppression implicates CD98 in integrin activation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Identification and characterization of a membrane protein (y+L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y+L. A candidate gene for lysinuric protein intolerance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Identification and characterization of a Na(+)-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Effect of 13-cis violaxanthin on organization of light harvesting complex II in monomolecular layers.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Genome sequence of the Brown Norway rat yields insights into mammalian evolution

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Amino acid transport system L is differently expressed in human normal oral keratinocytes and human oral cancer cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Humanization of an anti-p185HER2 antibody for human cancer therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

In vitro and in vivo anti-tumour effects of a humanised monoclonal antibody against c-erbB-2 product

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. The IDEC-C2B8 Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00770.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2008.00770.X

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34753908&oldid=1648036341"